41 results
Thumbnail

- D3.03 - Trend analysis of the occurrence of allergic diseases in Polish children over the past 30 years

Thumbnail

- D3.05 - Predictive Value of Bronchodilator Reversibility and FeNO in Assessing Positive Outcomes of Bronchial Provocation Tests in Asthma Patients

Thumbnail

- D3.02 - Benefits of non-invasive methods in the diagnosis of occupational asthma: example of asthma due to ammonium persulphate in a hairdresser

Thumbnail

- D3.07 - Allergic Asthma in Children: The Hidden Role of Cockroaches

Thumbnail

- D3.08 - Cross-disciplinary working in adult food allergy: experience from the UK

Thumbnail

- D3.10 - Systemic characteristic of 15-LOX and 5-LOX oxo-metabolites in older patients with aspirin exacerbated respiratory disease

Thumbnail

- D3.11 - Bird-Egg Syndrome and Beyond: Exploring Allergies to Egg Yolk and Seeds from Bird Feed Components

Thumbnail

- D3.12 - A case of Pneumothorax as first manifestation of asthma

Thumbnail

- D3.13 - Real-life experience with tezepelumab in severe allergic asthma

Thumbnail

- D3.14 - Validation of an environmental exposure chamber for the diagnosis of olive tree pollen allergy

Thumbnail

- D3.15 - Mislabeling of Anaphylaxis in the Emergency Department: A Retrospective Study at King Abdulaziz University Hospital, Jeddah

Thumbnail

D3.16 - Recommendations to travelers with pollen allergy, main pollens identified in aerobiological stations from Perú and Spain

Thumbnail

- D3.100 - Risk Factors and Biomarkers for COVID-19 and Allergic Diseases

Thumbnail

- D3.102 - PROMs Improvement Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps Patients: Real-life Experience

Thumbnail

- D3.103 - Impact of aspirin-induced bronchospasm on the in vitro Aspirin Hypersensitivity Diagnostic Index in the patients with Aspirin Exacerbated Respiratory Disease

Thumbnail

- D3.104 - A step towards standardized Clinical Remission Criteria for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): insights from a real-life study

Thumbnail

- D3.105 - Suspected EGPA in a patient on Dupilumab treatment: confirmed diagnosis of sarcoidosis - case report

Thumbnail

- D3.106 - Real-World Dupilumab Effectiveness Through 18 Months in Patients with CRSwNP and Coexisting Asthma: Results from the Global AROMA Registry

Thumbnail

- D3.108 - PTGDR2 Blood Expression as a Potential Biomarker for Predicting Super-Response to IL-5-Targeted Therapies in Severe Asthma

Thumbnail

D3.109 - Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis